BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-40. [PMID: 1579958 DOI: 10.1161/01.str.23.5.632] [Cited by in Crossref: 301] [Cited by in F6Publishing: 52] [Article Influence: 10.4] [Reference Citation Analysis]
Number Citing Articles
1 Tan G, Wang H, Chen S, Chen D, Zhu L, Xu D, Zhang Y, Liu L. Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis. Sci Rep 2017;7:16076. [PMID: 29167555 DOI: 10.1038/s41598-017-16355-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Truc My Nguyen T, van de Stadt SI, Groot AE, Wermer MJ, den Hertog HM, Droste HM, van Zwet EW, van Schaik SM, Coutinho JM, Kruyt ND. Thrombolysis related symptomatic intracranial hemorrhage in estimated versus measured body weight. Int J Stroke 2020;15:159-66. [PMID: 31092150 DOI: 10.1177/1747493019851285] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Irvine HJ, Battey TW, Ostwaldt AC, Campbell BC, Davis SM, Donnan GA, Sheth KN, Kimberly WT. Early neurological stability predicts adverse outcome after acute ischemic stroke. Int J Stroke 2016;11:882-9. [PMID: 27334760 DOI: 10.1177/1747493016654484] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM. Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag. 2014;10:75-87. [PMID: 24591838 DOI: 10.2147/VHRM.S39213] [Cited by in Crossref: 16] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
5 Pan Y, Shi G. Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window. Front Neurol 2021;12:593887. [PMID: 33732203 DOI: 10.3389/fneur.2021.593887] [Reference Citation Analysis]
6 Radecki RP. Pharmaceutical sponsorship bias influences thrombolytic literature in acute ischemic stroke. West J Emerg Med 2011;12:435-41. [PMID: 22224134 DOI: 10.5811/westjem.2011.5.2166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Marshall RS, Mohr JP. Current management of ischaemic stroke. J Neurol Neurosurg Psychiatry 1993;56:6-16. [PMID: 8429324 DOI: 10.1136/jnnp.56.1.6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
8 Haley MJ, Lawrence CB. Obesity and stroke: Can we translate from rodents to patients? J Cereb Blood Flow Metab 2016;36:2007-21. [PMID: 27655337 DOI: 10.1177/0271678X16670411] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 6.4] [Reference Citation Analysis]
9 Bustamante A, Mancha F, Macher HC, García-Berrocoso T, Giralt D, Ribó M, Guerrero JM, Montaner J. Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis. J Circ Biomark 2016;5:1849454416668791. [PMID: 28936264 DOI: 10.1177/1849454416668791] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
10 Anderson CS, Woodward M, Arima H, Chen X, Lindley RI, Wang X, Chalmers J; ENCHANTED Investigators. Statistical analysis plan for evaluating low- vs. standard-dose alteplase in the ENhanced Control of Hypertension and Thrombolysis strokE stuDy (ENCHANTED). Int J Stroke 2015;10:1313-5. [PMID: 26283139 DOI: 10.1111/ijs.12602] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
11 Mendioroz M, Fernández-Cadenas I, Rosell A, Delgado P, Domingues-Montanari S, Ribó M, Penalba A, Quintana M, Alvarez-Sabín J, Montaner J. Osteopontin predicts long-term functional outcome among ischemic stroke patients. J Neurol 2011;258:486-93. [PMID: 20967551 DOI: 10.1007/s00415-010-5785-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
12 Holodinsky JK, Yu AY, Assis ZA, Al Sultan AS, Menon BK, Demchuk AM, Goyal M, Hill MD. History, Evolution, and Importance of Emergency Endovascular Treatment of Acute Ischemic Stroke. Curr Neurol Neurosci Rep 2016;16:42. [PMID: 27021771 DOI: 10.1007/s11910-016-0646-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
13 Lyden PD. Measuring Outcome After Stroke: More Lessons Learned Again. Stroke 2020;51:1053-4. [PMID: 32102628 DOI: 10.1161/STROKEAHA.119.028214] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Xu N, Chen Z, Zhao C, Xue T, Wu X, Sun X, Wang Z. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials. Drug Des Devel Ther 2018;12:2071-84. [PMID: 30013325 DOI: 10.2147/DDDT.S170803] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
15 Kunte H, Schmidt S, Eliasziw M, del Zoppo GJ, Simard JM, Masuhr F, Weih M, Dirnagl U. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke. 2007;38:2526-2530. [PMID: 17673715 DOI: 10.1161/strokeaha.107.482216] [Cited by in Crossref: 115] [Cited by in F6Publishing: 58] [Article Influence: 8.2] [Reference Citation Analysis]
16 Dixon WC 4th, Harrington RA. Multi-bed vascular disease: past, present, and future. J Thromb Thrombolysis 2004;17:5-9. [PMID: 15277782 DOI: 10.1023/B:THRO.0000036023.14285.c5] [Reference Citation Analysis]
17 Bulwa Z, Gomez CR, Morales-Vidal S, Biller J. Management of Blood Pressure After Acute Ischemic Stroke. Curr Neurol Neurosci Rep 2019;19:29. [PMID: 31037389 DOI: 10.1007/s11910-019-0941-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Lou M, Selim M. Does body weight influence the response to intravenous tissue plasminogen activator in stroke patients? Cerebrovasc Dis 2009;27:84-90. [PMID: 19033683 DOI: 10.1159/000175766] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
19 Lyden PD. Thrombolytic Therapy for Acute Ischemic Stroke. Stroke 2019;50:2597-603. [PMID: 31327316 DOI: 10.1161/STROKEAHA.119.025699] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Bang OY, Park HY, Yoon JH, Yeo SH, Kim JW, Lee MA, Park MH, Lee PH, Joo IS, Huh K. Predicting the Long-Term Outcome after Subacute Stroke within the Middle Cerebral Artery Territory. J Clin Neurol 2005;1:148-58. [PMID: 20396462 DOI: 10.3988/jcn.2005.1.2.148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
21 Jia F, Du CC, Liu XG. Delayed massive cerebral infarction after perioperative period of anterior cervical discectomy and fusion: A case report. World J Clin Cases 2021; 9(28): 8602-8608 [DOI: 10.12998/wjcc.v9.i28.8602] [Reference Citation Analysis]
22 Dong Y, Han Y, Shen H, Wang Y, Ma F, Li H, Wang Y, Dong Q. Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis. Stroke Vasc Neurol 2020;5:348-52. [PMID: 32611728 DOI: 10.1136/svn-2020-000388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Porelli S, Leonardi M, Stafa A, Barbara C, Procaccianti G, Simonetti L. CT angiography in an acute stroke protocol: correlation between occlusion site and outcome of intravenous thrombolysis. Interv Neuroradiol 2013;19:87-96. [PMID: 23472730 DOI: 10.1177/159101991301900114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
24 Grotta J, Marler J. Intravenous rt-PA: a tenth anniversary reflection. Surg Neurol 2007;68 Suppl 1:S12-6. [PMID: 17963915 DOI: 10.1016/j.surneu.2007.07.079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
25 Becker LB, Aufderheide TP, Geocadin RG, Callaway CW, Lazar RM, Donnino MW, Nadkarni VM, Abella BS, Adrie C, Berg RA, Merchant RM, O'Connor RE, Meltzer DO, Holm MB, Longstreth WT, Halperin HR; American Heart Association Emergency Cardiovascular Care Committee., Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Primary outcomes for resuscitation science studies: a consensus statement from the American Heart Association. Circulation 2011;124:2158-77. [PMID: 21969010 DOI: 10.1161/CIR.0b013e3182340239] [Cited by in Crossref: 204] [Cited by in F6Publishing: 81] [Article Influence: 20.4] [Reference Citation Analysis]
26 Lindley RI. Thrombolysis in acute ischaemic stroke: a guide to patient selection. CNS Drugs 2005;19:539-51. [PMID: 15963002 DOI: 10.2165/00023210-200519060-00005] [Reference Citation Analysis]
27 Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP; Interventional Management of Stroke III Investigators. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke 2008;3:130-7. [PMID: 18706007 DOI: 10.1111/j.1747-4949.2008.00151.x] [Cited by in Crossref: 184] [Cited by in F6Publishing: 165] [Article Influence: 14.2] [Reference Citation Analysis]
28 Dong Y, Cao W, Cheng X, Fang K, Wu F, Yang L, Xie Y, Dong Q. Low-dose intravenous tissue plasminogen activator for acute ischaemic stroke: an alternative or a new standard? Stroke Vasc Neurol 2016;1:115-21. [PMID: 28959472 DOI: 10.1136/svn-2016-000033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 García-Berrocoso T, Llombart V, Colàs-Campàs L, Hainard A, Licker V, Penalba A, Ramiro L, Simats A, Bustamante A, Martínez-Saez E, Canals F, Sanchez JC, Montaner J. Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia. Mol Cell Proteomics 2018;17:175-89. [PMID: 29133510 DOI: 10.1074/mcp.RA117.000419] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
30 Pereira AC, Martin PJ, Warburton EA. Thrombolysis in acute ischaemic stroke. Postgrad Med J 2001;77:166-71. [PMID: 11222823 DOI: 10.1136/pmj.77.905.166] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
31 Meunier JM, Holland CK, Pancioli AM, Lindsell CJ, Shaw GJ. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots. Thromb Res 2009;123:528-36. [PMID: 18619651 DOI: 10.1016/j.thromres.2008.05.011] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
32 Orr SC, Gomez CR. Controversies about tissue plasminogen activator: extending the window of therapy. Curr Atheroscler Rep 2001;3:313-20. [PMID: 11389797 DOI: 10.1007/s11883-001-0025-8] [Reference Citation Analysis]
33 Tsivgoulis G, Alexandrov AV. Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety. Neurotherapeutics 2007;4:420-7. [PMID: 17599707 DOI: 10.1016/j.nurt.2007.05.012] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
34 Tomsick TA, Khatri P, Jovin T, Demaerschalk B, Malisch T, Demchuk A, Hill MD, Jauch E, Spilker J, Broderick JP; IMS III Executive Committee. Equipoise among recanalization strategies. Neurology 2010;74:1069-76. [PMID: 20350981 DOI: 10.1212/WNL.0b013e3181d76b8f] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
35 Kang J, Hong JH, Jang MU, Choi NC, Lee JS, Kim BJ, Han MK, Bae HJ. Change in blood pressure variability in patients with acute ischemic stroke and its effect on early neurologic outcome. PLoS One 2017;12:e0189216. [PMID: 29252991 DOI: 10.1371/journal.pone.0189216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
36 Akinseye OA, Shahreyar M, Heckle MR, Khouzam RN. Simultaneous acute cardio-cerebral infarction: is there a consensus for management? Ann Transl Med 2018;6:7. [PMID: 29404353 DOI: 10.21037/atm.2017.11.06] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
37 Bivard A, Lin L, Parsonsb MW. Review of stroke thrombolytics. J Stroke 2013;15:90-8. [PMID: 24324944 DOI: 10.5853/jos.2013.15.2.90] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 7.0] [Reference Citation Analysis]
38 Levine SR, Khatri P, Broderick JP, Grotta JC, Kasner SE, Kim D, Meyer BC, Panagos P, Romano J, Scott P; Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force:., NINDS rt-PA Stroke Trial Investigators. Review, historical context, and clarifications of the NINDS rt-PA stroke trials exclusion criteria: Part 1: rapidly improving stroke symptoms. Stroke 2013;44:2500-5. [PMID: 23847249 DOI: 10.1161/STROKEAHA.113.000878] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 5.4] [Reference Citation Analysis]
39 Cheng NT, Kim AS. Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset. Neurohospitalist 2015;5:101-9. [PMID: 26288668 DOI: 10.1177/1941874415583116] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 9.5] [Reference Citation Analysis]
40 Barreto AD. Intravenous thrombolytics for ischemic stroke. Neurotherapeutics 2011;8:388-99. [PMID: 21638138 DOI: 10.1007/s13311-011-0049-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
41 Ribo M, Rubiera M, Pagola J, Rodriguez-Luna D, Meler P, Flores A, Alvarez-Sabin J, Molina CA. Bringing forward reperfusion with oxygenated blood perfusion beyond arterial occlusion during endovascular procedures in patients with acute ischemic stroke. AJNR Am J Neuroradiol 2010;31:1899-902. [PMID: 20801767 DOI: 10.3174/ajnr.A2221] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
42 Lee JY, King C, Stradling D, Warren M, Nguyen D, Lee J, Riola MA, Montoya R, Patel D, Le VH, Welbourne SJ, Cramer SC. Influence of hematoma location on acute mortality after intracerebral hemorrhage. J Neuroimaging 2014;24:131-6. [PMID: 23279617 DOI: 10.1111/j.1552-6569.2012.00766.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
43 Yayan J. Onset of Orolingual Angioedema After Treatment of Acute Brain Ischemia with Alteplase Depends on the Site of Brain Ischemia: A Meta-analysis. N Am J Med Sci 2013;5:589-93. [PMID: 24350070 DOI: 10.4103/1947-2714.120794] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
44 Azad TD, Veeravagu A, Steinberg GK. Neurorestoration after stroke. Neurosurg Focus 2016;40:E2. [PMID: 27132523 DOI: 10.3171/2016.2.FOCUS15637] [Cited by in Crossref: 34] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
45 Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M; STAIR VI Consortium. Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke 2009;40:2594-600. [PMID: 19478212 DOI: 10.1161/STROKEAHA.109.552554] [Cited by in Crossref: 103] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
46 Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307-12. [PMID: 15883405 DOI: 10.1503/cmaj.1041561] [Cited by in Crossref: 309] [Cited by in F6Publishing: 251] [Article Influence: 19.3] [Reference Citation Analysis]
47 Guan W, Zhao Y, Xu C. A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window. Transl Stroke Res 2011;2:80-91. [PMID: 24323587 DOI: 10.1007/s12975-010-0050-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
48 Ryu WS, Woo SH, Schellingerhout D, Jang MU, Park KJ, Hong KS, Jeong SW, Na JY, Cho KH, Kim JT, Kim BJ, Han MK, Lee J, Cha JK, Kim DH, Lee SJ, Ko Y, Cho YJ, Lee BC, Yu KH, Oh MS, Park JM, Kang K, Lee KB, Park TH, Lee J, Choi HK, Lee K, Bae HJ, Kim DE. Stroke outcomes are worse with larger leukoaraiosis volumes. Brain 2017;140:158-70. [PMID: 28008000 DOI: 10.1093/brain/aww259] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
49 Tsivgoulis G, Alexandrov AV. Ultrasound enhanced thrombolysis: applications in acute cerebral ischemia. J Clin Neurol 2007;3:1-8. [PMID: 19513336 DOI: 10.3988/jcn.2007.3.1.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Montaner J, Salat D, García-Berrocoso T, Molina CA, Chacón P, Ribó M, Alvarez-Sabín J, Rosell A. Reperfusion therapy for acute stroke improves outcome by decreasing neuroinflammation. Transl Stroke Res 2010;1:261-7. [PMID: 24323553 DOI: 10.1007/s12975-010-0038-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]